Financials SYNLAB AG

Equities

SYAB

DE000A2TSL71

Healthcare Facilities & Services

Market Closed - Xetra 11:35:05 2024-06-06 am EDT After market 12:55:21 pm
11.12 EUR -0.54% Intraday chart for SYNLAB AG 11.12 0.00%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 5,244 2,510 2,509 2,457 - -
Enterprise Value (EV) 1 6,847 4,085 3,849 3,928 4,096 3,996
P/E ratio 8.39 x 16.6 x 27.2 x 30.2 x 37.3 x 37.3 x
Yield 1.4% 2.91% - 1.83% 1.83% 2.15%
Capitalization / Revenue 1.39 x 0.77 x 0.95 x 0.86 x 0.81 x 0.79 x
EV / Revenue 1.82 x 1.26 x 1.46 x 1.37 x 1.35 x 1.28 x
EV / EBITDA 5.66 x 5.43 x 8.79 x 7.1 x 6.8 x 6.34 x
EV / FCF 7.89 x 8.67 x 52 x 23.2 x -24.4 x 27.6 x
FCF Yield 12.7% 11.5% 1.92% 4.31% -4.1% 3.62%
Price to Book 2.32 x 1.07 x 1.08 x 1 x 0.96 x 0.92 x
Nbr of stocks (in thousands) 222,222 221,562 219,707 219,775 - -
Reference price 2 23.60 11.33 11.42 11.18 11.18 11.18
Announcement Date 3/16/22 3/16/23 3/25/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 3,765 3,251 2,635 2,862 3,024 3,130
EBITDA 1 - 1,210 753 437.9 553 602.5 630
EBIT 1 - 996.1 508 194.2 257 288.5 299
Operating Margin - 26.46% 15.63% 7.37% 8.98% 9.54% 9.55%
Earnings before Tax (EBT) 1 - 805.6 283 143 273 329 -82
Net income 1 257.6 624.8 151 92.27 81 67 67
Net margin - 16.6% 4.64% 3.5% 2.83% 2.22% 2.14%
EPS 2 - 2.811 0.6815 0.4200 0.3700 0.3000 0.3000
Free Cash Flow 1 - 867.2 471.4 74 169.4 -167.8 144.6
FCF margin - 23.03% 14.5% 2.81% 5.92% -5.55% 4.62%
FCF Conversion (EBITDA) - 71.68% 62.6% 16.9% 30.63% - 22.95%
FCF Conversion (Net income) - 138.8% 312.15% 80.2% 209.14% - 215.82%
Dividend per Share 2 - 0.3300 0.3300 - 0.2050 0.2050 0.2400
Announcement Date 4/20/21 3/16/22 3/16/23 3/25/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2023 Q1 2023 Q2
Net sales 1 992.6 1,061 790.4 1,851 697.9 702.4 669.7
EBITDA 1 - 356.9 171.1 528 135 118.5 113.5
EBIT - 300.1 110.7 410.8 75.8 60.5 -
Operating Margin - 28.28% 14% 22.19% 10.86% 8.61% -
Earnings before Tax (EBT) - - - - - - -
Net income - - - - - - -
Net margin - - - - - - -
EPS - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 3/16/22 5/12/22 8/11/22 8/11/22 11/10/22 5/12/23 8/9/23
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 1,602 1,575 1,340 1,471 1,639 1,539
Net Cash position 1 - - - - - - -
Leverage (Debt/EBITDA) - 1.324 x 2.092 x 3.06 x 2.659 x 2.72 x 2.442 x
Free Cash Flow 1 - 867 471 74 169 -168 145
ROE (net income / shareholders' equity) - 39% 14.9% 1.88% 3.4% 2.8% 2.7%
ROA (Net income/ Total Assets) - 12.6% 6.33% 0.88% - - -
Assets 1 - 4,949 2,386 10,532 - - -
Book Value Per Share 2 - 10.20 10.60 10.60 11.20 11.70 12.20
Cash Flow per Share 2 - 4.700 2.840 1.640 1.560 1.640 1.790
Capex 1 - 144 158 289 240 240 244
Capex / Sales - 3.84% 4.87% 10.97% 8.38% 7.94% 7.8%
Announcement Date 4/20/21 3/16/22 3/16/23 3/25/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
11.18 EUR
Average target price
14.5 EUR
Spread / Average Target
+29.70%
Consensus

Quarterly revenue - Rate of surprise